Biotech, Clinical Trials, Industry, Research and Development
April 21, 2020
Via: Biopharma DiveCara’s hypothesis in developing Korsuva was that by acting on opioid receptors, the experimental drug could provide relief from itching without leading to addiction. Rather than stimulating the mu-opioid receptor, like morphine and other pain drugs with addictive potential, Korsuva […]
July 19, 2024
July 11, 2024
July 11, 2024